Delisting riskPopularity #3,970
GT Biopharma (GTBP)
Developer of natural-killer-cell engagers for cancer and autoimmune disease.
$6.96
After hours−0.14 (−1.97%)
At close$7.10(−1.11%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
in 51 days
EPS estimate
−$2.50
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.67−$0.33−$0.55−$0.83−$55.50−$0.11−$3.00Pending
Estimate−$38.75−$16.00−$17.00−$9.50−$5.50−$2.00−$2.00−$2.50
Surprise+95.7%+97.9%+96.8%+91.3%−909.1%+94.5%−50.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$2.50 | — | — |
| Nov 2026 | −$2.50 | — | — |
| Aug 2026 | −$2.00 | −$3.00 | −50.0% |
| May 2026 | −$2.00 | −$0.11 | +94.5% |
| Mar 2026 | −$5.50 | −$55.50 | −909.1% |
| Nov 2025 | −$9.50 | −$0.83 | +91.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Apr 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Apr 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$2.50 | — | — | $0 | — | — | — |
| Nov 13, 2026 | −$2.50 | — | — | $0 | — | — | — |
| Aug 14, 2026 | −$2.00 | −$3.00 | −50.0% | — | — | — | −0.5% |
| May 21, 2026 | −$2.00 | −$0.11 | +94.5% | — | — | — | +3.3% |
| Mar 2, 2026 | −$5.50 | −$55.50 | −909.1% | — | — | — | +0.6% |
| Nov 13, 2025 | −$9.50 | −$0.83 | +91.3% | — | — | — | +0.7% |
| Aug 13, 2025 | |||||||
| May 21, 2025 | |||||||
| Mar 25, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 16, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Oct 31, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 23, 2021 | |||||||
| May 17, 2021 | |||||||
| Apr 16, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 27, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 11, 2017 | |||||||
| Apr 28, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 10, 2016 | |||||||
| May 13, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Aug 14, 2015 |